Closed
Exercise
Calculated transaction value
$0

Megna Michael R Chief Accounting Officer

Transaction date Oct 30, 2026
Public filing date Nov 3, 2026
Filing lag Filed 4 days later

KNSA daily price context

Close on/before transaction
$92.24 Oct 30, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Share Option on Class A Ordinary Share
Quantity / price
7,209 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001464583-26-000010
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$3.68M
Buys / sales
0 / 7
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $50.45K
Kiniksa Pharmaceuticals International, Plc KNSA Current Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $895.65K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $86.29K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $72.19K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $633.71K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $351.46K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $43.65K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $553.98K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $164.21K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $522.91K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $302.17K